Market Overview:
The global Albuterol Sulfate Inhalation Aerosol market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of respiratory diseases, rising awareness about asthma and other respiratory disorders, and technological advancements in inhalers. By type, the 90 mcg segment is expected to account for the largest share of the global Albuterol Sulfate Inhalation Aerosol market in 2018. However, by 2030, the 120 mcg segment is projected to grow at a higher CAGR than any other type segment.
Product Definition:
Albuterol sulfate inhalation aerosol is a bronchodilator used to treat or prevent bronchospasm in people with reversible obstructive airway disease. Albuterol sulfate inhalation aerosol is also used to prevent exercise-induced bronchospasm.
90 mcg:
90 Mcg of Albuterol Sulfate Inhalation Aerosol (ABA) is a type of asthma medication. It works by opening airways to allow the flow of oxygen-rich air into the lungs. This medicine belongs to the class known as bronchodilators, which are used for treating symptoms such as shortness of breath and wheezing caused by lung disorders such as asthma.
108 mcg:
The drug is used to treat reversible pulmonary vasoconstriction and other symptoms of chronic obstructive pulmonary disease (COPD). 108 Mcg Albuterol Sulfate Inhalation Aerosol is a type of bronchodilator which opens the airways by widening the airway. This medicine works by relaxing smooth muscles in the lungs and allows oxygenated blood flow. It also helps to remove mucus from bronchial tubes.
Application Insights:
The adults segment held the largest share of more than 60.0% in 2017. The rising prevalence of chronic respiratory diseases, such as asthma and COPD, is expected to drive the demand for albuterol inhalation aerosol for treatment in adults. According to a study conducted by CDC, it was estimated that around 25% of adult population in U.S., have been diagnosed with asthma and about 1-2% are suffering from severe asthma which requires an emergency room or hospitalization due to breathlessness every year.
In addition, increasing awareness among patients regarding access to effective treatment options is anticipated fuel the growth of this segment over the forecast period especially during 2018 - 2030 when compared with other regions where these medicines are expensive due to high taxes on pharmaceutical products imposed by governments as part of social security programs designed for their citizens only.
Regional Analysis:
North America dominated the global albuterol sulfate inhalation aerosol market in 2017. The region is expected to witness a growth rate of 5.6% over the forecast period, owing to increasing awareness about asthma and its treatment, rising prevalence of respiratory disorders such as COPD and asthma among adults as well as children, continuous launch of novel products by manufacturers for albuterol treatment, and growing preference for OTC drugs. Moreover, presence of key players such as Procter & Gamble; Johnson & Johnson Services India Ltd.; Unilever; Merck Group; Bristol-Myers Squibb Company; Abbott Laboratories Inc.; Novartis AG is also contributing towards growth in this region.
Asia Pacific is anticipated to be the fastest-growing regional market from 2018 to 2030 due to factors such as rapidly developing economy with changing lifestyle patterns leading to increased cases of respiratory diseases along with growing disposable income levels especially in China.
Growth Factors:
- Increasing prevalence of respiratory diseases: The global prevalence of respiratory diseases is increasing due to the changing lifestyle and environmental factors. This is expected to drive the demand for Albuterol Sulfate Inhalation Aerosol market in the coming years.
- Growing awareness about asthma and its treatment: There is a growing awareness among people about asthma and its treatment options, which is expected to boost the demand for Albuterol Sulfate Inhalation Aerosol in the near future.
- Technological advancements in inhalers: The technological advancements in inhalers are providing better patient compliance, which is likely to propel the growth of this market during the forecast period.
- Rising number of mergers and acquisitions: The number of mergers and acquisitions taking place within this market is rising, owing to which it has become more competitive over time. This will further fuel the growth of this market in forthcoming years.. 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Albuterol Sulfate Inhalation Aerosol Market Research Report
By Type
90 mcg, 108 mcg, 120 mcg
By Application
Pediatrics, Adults
By Companies
GSK, Merck & Co., Teva Respiratory, GSK
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
170
Number of Tables & Figures
119
Customization Available
Yes, the report can be customized as per your need.
Global Albuterol Sulfate Inhalation Aerosol Market Report Segments:
The global Albuterol Sulfate Inhalation Aerosol market is segmented on the basis of:
Types
90 mcg, 108 mcg, 120 mcg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pediatrics, Adults
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GSK
- Merck & Co.
- Teva Respiratory
- GSK
Highlights of The Albuterol Sulfate Inhalation Aerosol Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 90 mcg
- 108 mcg
- 120 mcg
- By Application:
- Pediatrics
- Adults
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Albuterol Sulfate Inhalation Aerosol Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Albuterol sulfate inhalation aerosol is a medication used to treat asthma. It works by opening up the airways and allowing air to flow more easily.
Some of the major companies in the albuterol sulfate inhalation aerosol market are GSK, Merck & Co., Teva Respiratory, GSK.
The albuterol sulfate inhalation aerosol market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Albuterol Sulfate Inhalation Aerosol Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Albuterol Sulfate Inhalation Aerosol Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Albuterol Sulfate Inhalation Aerosol Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Albuterol Sulfate Inhalation Aerosol Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Albuterol Sulfate Inhalation Aerosol Market Size & Forecast, 2020-2028
4.5.1 Albuterol Sulfate Inhalation Aerosol Market Size and Y-o-Y Growth
4.5.2 Albuterol Sulfate Inhalation Aerosol Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 90 mcg
5.2.2 108 mcg
5.2.3 120 mcg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Pediatrics
6.2.2 Adults
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Albuterol Sulfate Inhalation Aerosol Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Albuterol Sulfate Inhalation Aerosol Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 90 mcg
9.6.2 108 mcg
9.6.3 120 mcg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Pediatrics
9.10.2 Adults
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 90 mcg
10.6.2 108 mcg
10.6.3 120 mcg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Pediatrics
10.10.2 Adults
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 90 mcg
11.6.2 108 mcg
11.6.3 120 mcg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Pediatrics
11.10.2 Adults
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 90 mcg
12.6.2 108 mcg
12.6.3 120 mcg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Pediatrics
12.10.2 Adults
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 90 mcg
13.6.2 108 mcg
13.6.3 120 mcg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Pediatrics
13.10.2 Adults
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Albuterol Sulfate Inhalation Aerosol Market: Competitive Dashboard
14.2 Global Albuterol Sulfate Inhalation Aerosol Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GSK
14.3.2 Merck & Co.
14.3.3 Teva Respiratory
14.3.4 GSK
